Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Articles
Articles
Addressing Challenges to Adoption of Value-Based Agreements
By
Phoebe Starr
AVBCC 2023 Summit
,
AVBCC
December 2023, Vol 14, No 6
In a session during the 13th Annual Summit of the Association for Value-Based Cancer Care, held October 18-20, 2023, in New York City, Linde Wilson, MBA, Managing Partner, HealthQuest Advisors, discussed the ongoing challenges related to the development and implementation of value-based agreements.
Read More
Phase 3 Trials Show Superiority of Targeted Treatments Over Chemotherapy in Oncogene-Addicted NSCLC
By
William King
Lung Cancer
,
ESMO 2023 Highlights
December 2023, Vol 14, No 6
Madrid, Spain—Results from 3 phase 3 clinical trials demonstrated the superiority of targeted therapies over conventional chemotherapy in patients with oncogene-addicted non–small cell lung cancer (NSCLC), including
ALK
-positive advanced NSCLC;
EGFR
exon 20 insertion-mutation–positive, newly diagnosed or advanced NSCLC; and advanced
RET
fusion–positive NSCLC. These findings were reported during the European Society for Medical Oncology Congress 2023.
Read More
Braftovi Plus Mektovi Now FDA Approved for Treatment of Metastatic NSCLC With BRAF Mutation
FDA Approvals, News & Updates
December 2023, Vol 14, No 6
On
October 11, 2023
, the FDA approved a new indication for encorafenib (Braftovi; Array BioPharma) combined with binimetinib (Mektovi; Array BioPharma) for adults with metastatic non–small cell lung cancer (NSCLC) and a
BRAF
V600E
mutation, as detected by an FDA-approved test.
Read More
Highlights From the 5th Annual Cholangiocarcinoma Summit
By
Ashley Gamble, PharmD
Cholangiocarcinoma
December 2023, Vol 14, No 6
The 5th Annual Cholangiocarcinoma Summit, held October 19 to 21, 2023, in Scottsdale, AZ, brought together experts from around the world to discuss the latest research and clinical data pertaining to the diagnosis and treatment of patients with CCA and other biliary track cancers.
Read More
Rozlytrek Now Approved for Pediatric Patients Older Than 1 Month With Solid Tumors and NTRK Gene Fusion and in New Oral Pellet Form
FDA Approvals, News & Updates
December 2023, Vol 14, No 6
On
October 20, 2023
, the FDA accelerated the approval of the tyrosine kinase inhibitor entrectinib (Rozlytrek; Genentech) for the treatment of pediatric patients aged >1 month who are diagnosed with metastatic solid tumors associated with an
NTRK
gene fusion, as detected by an FDA-approved test, and no known acquired resistance mutation or whose disease is likely to lead to severe morbidity and has progressed after previous treatment, or patients who have no satisfactory standard therapy.
Read More
Oncology and Vertically Integrated Supply Channels
AVBCC 2023 Summit
AVBCC Highlights
Supply channels are becoming more and more complex, and their models are evolving with an abundance of services to support both the providers and suppliers. Such complexity is causing both challenges and opportunities in this arena. What does the future hold?
Read More
Evolution of Clinical Trials
AVBCC 2023 Summit
AVBCC Highlights
Clinical trials have evolved over the years from gated phase 1, 2, and 3 approaches to more blended phase options and single-arm trials. However, we’re still seeing many of the same challenges, such as lack of patient access and diversity, similar or rising cost, and increasing complexity. Our panel of experts discussed the evolution of clinical trials and some unique solutions being considered for the future.
Read More
A View on Legislation and Policy Out of Washington Ahead
AVBCC 2023 Summit
AVBCC Highlights
From the Pharmacy Benefits Manager (PBM) Reform Act and 340B Drug Pricing Program to drug shortages and the Inflation Reduction Act, this panel of Washington healthcare experts separated fact from fiction and noise from reality to provide a clear understanding for current legislative priorities.
Read More
Cancer Research and the Road Ahead
AVBCC 2023 Summit
AVBCC Highlights
Cancer treatments are advancing rapidly, thanks to the diligence of researchers and the foundations that support them. Panelists discussed emerging therapies, the impact of funding organizations, and what the future holds for the fight against cancers.
Read More
AI and ML Decision Support Models
AVBCC 2023 Summit
AVBCC Highlights
Artificial intelligence (AI) and machine learning (ML) platforms are becoming essential to the value equation in healthcare and to managing the complexity and range of treatment options within cancer care today. Panelists in this session explored the application of AI and ML technologies and their impact on care, outcomes, cost, providers, pharma, payers, and patients as well as their integrations between electronic medical records and future systems.
Read More
Page 2 of 338
1
2
3
4
5
6
7
8
9
10
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Medication Assurance Programs, as Deceiving and Harmful as Alternate Funding Programs
Dawn Holcombe, MBA, FACMPE, ACHE
2.
Addressing Challenges to Adoption of Value-Based Agreements
Phoebe Starr
3.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma